Wilson Mark Andrew — SEC Form 4 filings
SEC reporting owner CIK 1808356. 11 Form 4 filings on record with FilingPulse; latest filed 2026-02-10.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-22 to 2026-02-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 9 filings — 98,228 shares, $144,651 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 630 shares @ $54.28 ($34,196) in NEKTAR THERAPEUTICS, filed 2025-11-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | Chief Legal Officer | 10 | — | 10 legs · 98,228 sh · $144,651 | 6 |
| Septerna, Inc. (SEPN) | Chief Legal Officer | 1 | — | — | 1 |
Form 4 filings — Wilson Mark Andrew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-10 | 4 | Septerna, Inc. (SEPN) | Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 1,903 @ $0 · Sale (S): 630 @ $54.28 · Grant/award (A): 3,400 (derivative) @ $0 | EDGAR |
| 2025-08-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 676 @ $26.59 · Grant/award (A): 21,666 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 9,996 @ $0.67 | EDGAR |
| 2025-02-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 11,040 @ $1.01 | EDGAR |
| 2024-12-26 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 33,402 @ $0.90 · Sale (S): 16,560 @ $0.89 | EDGAR |
| 2024-12-17 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 165,938 @ $0 · Grant/award (A): 331,875 (derivative) @ $0 · Grant/award (A): 325,000 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 6,407 @ $1.01 | EDGAR |
| 2024-08-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 5,651 @ $1.28 | EDGAR |
| 2024-05-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 6,260 @ $1.75 | EDGAR |
| 2024-02-22 | 4 | NEKTAR THERAPEUTICS (NKTR) | Sale (S): 7,606 @ $0.68 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1808356 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →